Target intelligence / Profile preview

Mycobacterial F1FO-ATP synthase subunit c (atpE)

Target
atpE
Molecular classification
Enzyme, Transporter, ATP synthase
01

Overview

The Mycobacterial F1FO-ATP synthase subunit c, commonly known as the c-ring, is a critical component of the energy-producing machinery in mycobacteria, including Mycobacterium tuberculosis (Andries et al., 2005, Science). It forms a transmembrane ring structure within the FO sector of the ATP synthase enzyme, functioning as a rotary motor driven by the proton motive force (Preiss et al., 2015, PNAS). As protons move through the interface between the c-ring and the 'a' subunit, the ring rotates, providing the mechanical energy required for the F1 sector to synthesize ATP from ADP and inorganic phosphate (Koul et al., 2007, Nature). This process is essential for the survival of both actively replicating and dormant mycobacteria, making it a highly effective therapeutic target (UniProt P9WPU1). The diarylquinoline drug Bedaquiline targets this subunit by binding to a specific pocket, which physically blocks the rotation of the c-ring and halts ATP production (Preiss et al., 2015, PNAS). This inhibition results in a rapid depletion of cellular energy and eventual bacterial death, providing a breakthrough treatment for multi-drug-resistant tuberculosis (Mahajan, 2013, International Journal of Applied and Basic Medical Research).

Other names
ATP synthase subunit cF-type H+-transporting ATPase subunit cF0 complex subunit cMycobacterial ATP synthase c-ringATP synthase C chain
02

Mechanism of action

Bedaquiline and its derivatives bind to the c-ring of the F0 subunit of the mycobacterial ATP synthase, specifically interacting with the ion-binding site (e.g., Glu61 in M. tuberculosis). This binding physically obstructs the rotation of the c-ring, which is essential for proton translocation across the membrane, thereby inhibiting the synthesis of ATP and leading to bacterial cell death (Andries et al., 2005, Science; Preiss et al., 2015, PNAS).

03

Biological functions

ATP synthesisProton transportEnergy metabolismRotary catalysis
04

Disease associations

InfectionTuberculosisLeprosyNontuberculous mycobacterial infection
05

Safety considerations

QT interval prolongationHepatotoxicityIncreased risk of mortality (observed in Bedaquiline clinical trials)Drug-drug interactions via CYP3A4 induction/inhibition
06

Interacting drugs

Bedaquiline

2 more in the full profile.

07

Biomarkers

atpE gene mutations (resistance marker)Sputum culture conversionTime to culture positivity

Beyond the preview

Go deeper on Mycobacterial F1FO-ATP synthase subunit c (atpE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial F1FO-ATP synthase subunit c (atpE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call